(MENAFNEditorial)
Santa Monica CA May 29th 2015 – PRBuzz - Leonhardt Ventures a product development and venture creation laboratory focused on cardiovascular therapies and its 50.1% controlled subsidiary Cal-X Stars Business Accelerator Inc. announced today that it has engaged a process working with Healthiosxchange and others to explore strategic options for its line up of microcurrent energy devices that via triggering a stem cell homing signal are designed to direct stem cell regeneration of damaged organs and tissues.
"We are seeking regional or global collaborators to rapidly conduct required clinical trials and to pursue the approval distribution and marketing of these products for various applications” said Howard J. Leonhardt Inventor Founder and CEO.
Leonhardt Venture's is engaging its full 70+ person business advisory team - http://calxstars.com/team-cal-x/ and 35 scientific advisory board members in this process - http://calxstars.com/scientific-advisory-board/ as well as Healthiosxchange www.healthiosxchange.com
The team in particular will focus on securing a strategic development partner for Leonhardt’s flagship startup BioLeonhardt MyoStim
www.bioleonhardt.com + www.myostimpacers.com that is developing a combination implantable programmable re-fillable stem cell/growth factor pump and microcurrent regeneration stimulator device for regenerating damaged and weakened hearts. Leonhardt formerly founded Bioheart Inc. in 1999 and intends to facilitate and sponsor clinical trials of the delivery of Bioheart's MyoCell and MyoCell SDF-1 via this implantable pump + stimulator delivery system along with other supporting agents such as nutrient hydrogel and various growth factors. Bioheart's MyoCell has been in clinical trials since early 2001. Pre-clinical studies have demonstrated that repeat doses electrical stimulation nutrient hyrogel and various growth factors such as stromal derived growth factor SDF-1 vascular endothelial growth factor VEGF and hepatocyte growth factor all three stimulated by the BioLeonhardt MyoStim device can improve functional improvement results. Creating more new contractile muscle in heart scar tissue and a higher volume of mature (true endothelium lining) nutrient providing blood vessels.
Other Leonhardt Ventures’ Cal-X Stars Business Accelerator Inc. startups include:
· Stem Cell Bra – Breast regeneration following cancerous tissue removal – www.stemcellbra.com
· BioPace –biological pacemaker made entirely of living cells - http://www.leonhardtventures.com/biopace.php
· CoroStim – vibrational energy emitting pacemaker that prevents plaque formation in high risk coronary arteries.
· CerebraCell – microcurrent based non-invasive energy system for brain recovery following stroke or injury. Non-invasive cerebral aneurysm repair – http://leonhardtventures.com/cerebracell.php. Alzheimer's and Parkinson's treatment. Concussion recovery.
· AortaCell - Aortic aneurysm repair with non-invasive microcurrent energy. http://www.leonhardtventures.com/aortacell.php ;
· EndoCell – Blood vessel artery regeneration.
· EyeCell – Eye regeneration - http://www.leonhardtventures.com/eyecell.php
· DentaCell – Dental gum and teeth regeneration - http://www.leonhardtventures.com/denta-call.php
· Valvublator – Heart valve regeneration www.valvublator.com + ;http://www.leonhardtventures.com/valbulator.php
These startups operate legally as subsidiaries of Leonhardt Vineyards LLC DBA Leonhardt Ventures within the Cal-X Stars Business Accelerator Inc. until they are strong enough to be self reliant and stand alone as a California C corporation.
Leonhardt Ventures is developing both non-invasive wireless microcurrent energy healing systems as well as implantable and wire based systems.
Working with Dr. Joseph Ventura of Axion of Kansas Leonhardt Ventures secured conditional rights to a programmable U.S. 510K market cleared microcurrent stimulator http://www.myostimpacers.com/microcurrent-stimulators.php which it is currently marketing into the peripheral vascular market for the treatment of diabetic foot ulcers and associated pain.
Full information on the full Cal-X Stars Business Accelerator Inc. portfolio of incubating startups may be found on the Healthiosxchange platform at - http://www.healthiosxchange.com/capitalsource/LeonhardtVenturesCal-XStars Limited to accredited investors only under 506D part C. Healthiosxchange offers accredited investor verification services as well as self directed IRA assistance via PIMCO.
Contact Company:
Howard J. Leonhardt
Executive Chairman & CEO
Leonhardt Ventures
www.leonhardtventures.com
Cal-X Stars Business Accelerator Inc.
www.calxstars.com
1531 6th Street Unit 401
Santa Monica CA 90401
Office: 310 310 2534
Email: hleonhardt@aol.com or howardleohardt@gmail.com
About Healthiosxchange: The HealthiosXchange www.healthioxschange.com is the premiere investment marketplace dedicated exclusively to the global healthcare industry. Employing crowd funding as the cornerstone of a new paradigm in healthcare investing the HealthiosXchange offers direct access to the broadest investment opportunities on a "Fee Free Carry Free" basis in the most trusted online environment. The HealthiosXchange is an affiliate of Healthios Capital Markets LLC. a FINRA-regulated broker dealer based in Chicago with offices in Boston London Geneva and Bangkok. Healthioxchange is a leader in self directed IRA financings with accredited investors into syndicates led by proven track record industry leaders.
Healthiosxchange is the official listing board for the the Cal-X Stars Business Accelerator Inc. $15 million offering via 506D part C. This exemption allows general solicitation and up to 2000 accredited investors. Any potential investor's accredited status must be verified by a broker lawyer accountant or other verifiable means. Cal-X Stars Business Accelerator is incubating/accelerating by charter 15 cardiovascular and 15 social good impact startup innovations with intention to start auctioning them off to the highest bidders on or before May 11th 2018. By charter Cal-X Stars Business Accelerator Inc will not accept any self directed IRA investments that exceed 10% of a person's IRA total portfolio and we recommend 5% due to the very high risk nature of investing in early stage cardiovascular and social good impact startups such as those incubating within the Cal-X Stars accelerator. Any potential investor should read ALL risk factors published in our private placement memorandum.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.